Hambleton Julie

CIK 00015787715 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001578771

Recent Transactions

50 trades

Disposition to Issuer
IGM Biosciences, Inc.
Common Stock
2025-08-14−2,000→ 0 total
Disposition to Issuer
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-01−15,318→ 0 total
Disposition to Issuer
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-01−14,668→ 0 total
Disposition to Issuer
SpringWorks Therapeutics, Inc.
Common Stock
2025-07-01−14,155→ 0 total
Disposition to Issuer
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-01−12,216→ 0 total
Award
Erasca, Inc.$ERAS
Stock option (right to buy)
2025-06-24+120,000→ 120,000 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2025-05-14+10,060→ 14,155 total
Exercise/Conversion
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2025-02-10−13,774→ 0 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2025-02-10$53.01/sh−13,774→ 4,095 total
Exercise/Conversion
SpringWorks Therapeutics, Inc.
Common Stock
2025-02-10$32.27/sh+13,774→ 17,869 total
Exercise/Conversion
IGM Biosciences, Inc.
Common Stock
2024-07-25$1.39/sh+15,132→ 17,132 total
Sale
IGM Biosciences, Inc.
Common Stock
2024-07-25$14.00/sh−15,132→ 2,000 total
Exercise/Conversion
IGM Biosciences, Inc.
Stock Option (right to buy)
2024-07-25−15,132→ 0 total
Award
Erasca, Inc.$ERAS
Stock Option (right to buy)
2024-06-20+60,000→ 60,000 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2024-06-03$39.41/sh−2,946→ 5,797 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2024-06-03$41.49/sh−931→ 4,115 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2024-06-03$40.57/sh−751→ 5,046 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2024-06-03$42.09/sh−20→ 4,095 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2024-05-16+12,216→ 12,216 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2024-05-16+4,095→ 8,743 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2024-03-12+29,400→ 29,400 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2023-07-19$29.31/sh−2,418→ 4,648 total
Award
Erasca, Inc.$ERAS
Stock Option (right to buy)
2023-06-22+60,000→ 60,000 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2023-06-20$26.92/sh−2,400→ 7,066 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2023-05-24+4,648→ 9,466 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-24+13,774→ 13,774 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2023-04-04+15,500→ 15,500 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2023-03-15$31.50/sh−1,106→ 4,818 total
Award
Erasca, Inc.$ERAS
Stock Option (right to buy)
2022-06-22+40,000→ 40,000 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2022-05-19+15,318→ 15,318 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2022-05-19+4,818→ 5,924 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2022-03-12+29,497→ 29,497 total
Sale
IGM Biosciences, Inc.
Common Stock
2021-08-09$80.00/sh−1,000→ 2,000 total
Purchase
Erasca, Inc.$ERAS
Common Stock
2021-07-20$16.00/sh+6,000→ 6,000 total
Sale
IGM Biosciences, Inc.
Common Stock
2021-06-01$80.00/sh−2,000→ 3,000 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2021-05-20+1,106→ 5,995 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2021-05-20+6,998→ 6,998 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2021-02-19+6,423→ 6,423 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-20+14,668→ 14,668 total
Award
IDEAYA Biosciences, Inc.$IDYA
Stock Option (right to buy)
2020-02-21+62,500→ 62,500 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2020-02-05+10,000→ 10,000 total
Purchase
IGM Biosciences, Inc.
Common Stock
2019-09-18$18.31/sh+5,000→ 5,000 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2019-09-17+12,100→ 12,100 total
Sale
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2015-11-11$35.33/sh−1,108→ 84,811 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2015-11-11−10,000→ 14,390 total
Sale
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2015-11-11$34.75/sh−6,600→ 89,319 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2015-11-11−12,000→ 38,000 total
Sale
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2015-11-11$35.23/sh−3,400→ 85,919 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2015-11-11$11.14/sh+12,000→ 97,919 total
Sale
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2015-11-11$34.33/sh−12,000→ 85,919 total

Companies

Recent Filings

Address

C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov